Latinos Understanding the Need for Adherence in Diabetes Using E-Health
Launched by SAN DIEGO STATE UNIVERSITY · Oct 4, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The LUNA-E trial is a study designed to help Latino patients with type 2 diabetes better manage their condition and improve their overall well-being. This research focuses on using a team-based approach that combines medical care with support for mental health, along with technology tools to enhance communication and care. The main goal is to see if this patient-centered method can lower blood sugar levels (measured by hemoglobin A1C) and reduce feelings of anxiety and depression among participants.
To join the study, individuals must be 18 years or older, identify as Hispanic or Latino, and have type 2 diabetes with a recent blood sugar level above 7.5%. Participants need to be registered patients at a certain health center and have approval from their primary care provider. They should not be involved in other diabetes programs or have serious health issues that could prevent them from taking part. If selected, participants can expect to receive tailored support and resources over the course of the trial, which aims to improve their health and quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Self identify as Hispanic/Latino ethnicity of any race
- • 2. Registered patient of federally qualified health center
- • 3. 18 years of age or older
- • 4. Type 2 diabetes with hemoglobin A1C (HbA1c) \>7.5% in past 90 days
- • 5. Approval from primary care provider
- • 6. Not currently enrolled/participating in any other diabetes intervention program(s)
- Exclusion Criteria:
- • 1. Actively being treated for cancer or Parkinson's Disease
- • 2. Pregnant or nursing (temporary exclusion, may qualify 6-months postpartum)
- • 3. Have plans to move out of the area in the next 12 months
- • 4. Have other existing mental or physical health problems so severe as to prohibit informed consent and participation
- • 5. Have severe diabetes complications (e.g., renal disease, or on dialysis)
About San Diego State University
San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chula Vista, California, United States
Patients applied
Trial Officials
Gregory A Talavera, MD/MPH
Principal Investigator
San Diego State University
Linda C Gallo, PHD
Principal Investigator
San Diego State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials